EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer.

Por Su-Ni Tang, Junsheng Fu, Sharmila Shankar, Rakesh K Srivastava
Publicado em 2012-01-01